Back to search

Article

Evolving or Immutable - Phase I Solid Tumor Trials in the Era of Precision Oncology

2024-04-29

Abstract excerpt

<title>Abstract</title> <p>Purpose In the era of precision oncology (PO), systemic therapies for patients (pts) with solid tumors have shifted from chemotherapy (CT) to targeted therapy (TT) and immunotherapy (IO). This systematic survey describes features of trials enrolling between 2010-2020, focusing on inclusion criteria, type of dose escalation scheme (DES) utilized, and use of expansion cohorts (ECs). Metho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d2048adf-38a6-522d-a1fc-97b4e5a3ba2c
DOI
10.21203/rs.3.rs-4202155/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evolving or Immutable - Phase I Solid Tumor Trials in the Era of Precision OncologyDOI 10.21203/rs.3.rs-4202155/v1
Select a neighboring publication to make it the new centre.